TNF and inflammatory bowel disease: Despite anti-inflammatory properties, anti-TNFα agents, including those used for the treatment of IBD, such as infliximab and adalimumab, have also paradoxically been demonstrated to trigger uveitis, which will be further discussed below [8,13].